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A novel polymorphism in the proximal UCP3
promoter region: effect on skeletal muscle UCP3
mRNA expression and obesity in male non-
diabetic Pima Indians
P Schrauwen2, J Xia3*, K Walder3, S Snitker3 and E Ravussin1
1Lilly Corporate Center, Indianapolis, USA; 2Department of Human Biology, Maastricht University, Maastricht, The Netherlands;
3Clinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health,
Phoenix, Arizona, USA
OBJECTIVE: UCP2 and UCP3 are newly discovered uncoupling proteins, which are thought to underlie the variability
in energy metabolism in humans. Mutations in the UCP2 and=or UCP3 gene have been associated with sleeping
metabolic rate. Recently we reported that skeletal muscle UCP3 mRNA expression was positively correlated with
sleeping metabolic rate in Pima Indians. To study whether genetic variation in the promoter region of UCP3
contributed to the variation in expression of UCP3, we screened part of the proximal promoter region for
polymorphisms.
METHODS: In the ®rst part of the study, the proximal promoter region of UCP3 was screened by direct sequencing in
24 non-diabetic Pima Indians (range body mass index (BMI): 18 ± 47 kg=m2) (Schrauwen et al. Diabetes 1999; 48: 146 ±
149) and skeletal muscle UCP3 mRNA expression was measured by RT-PCR. In the second part of the study, we typed
the polymorphism found in the ®rst part of the study in 67 Pima Indians (32 males, 35 females) from the upper and
lower extremes of the BMI distribution.
RESULTS: We identi®ed a novel C to T substitution in the UCP3 promoter, 6bp upstream of the putative TATA signal,
and 55 bp upstream of the transcription starting site. Among 18 male subjects, skeletal muscle UCP3 mRNA
expression was signi®cantly higher in the C=T & T=T group compared to the C=C homozygotes (P< 0.02). However,
in the group of 67 Pima Indians genotype frequencies were not different in the obese and lean groups.
CONCLUSION: We identi®ed a novel polymorphism in the proximal promoter region of UCP3, which was associated
with increased skeletal muscle expression of UCP3 in male non-diabetic Pima Indians. Considering the suggested role
of UCP3 in energy metabolism, this polymorphism might be of physiological importance in the regulation of energy
balance.
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Introduction
The interest in the study of energy metabolism has
recently been renewed by the discovery of two new
mitochondrial proteins, UCP2 and UCP3, which exhi-
bit uncoupling activity.1,2 UCP2 is widely expressed,1
with abundant expression in adipose tissue and skele-
tal muscle, while UCP3 is predominantly expressed in
skeletal muscle.3 UCP3 is expressed equally (ratio
1:1) as a long and a short form, the latter lacking exon
7, which results in a truncated protein.3 These uncou-
pling proteins are likely candidates to underlie the
variability in energy metabolism in humans and may
thus be involved in the development of obesity.
UCP2 maps to chromosome 11q131 and UCP3 is
thought to be only 8 kb away from UCP2.4 Urhammer
et al5 reported a common polymorphism in the UCP2
gene. This polymorphism, a single nucleotide substi-
tution, which results in an alanine to a valine amino
acid substitution at position 55, was not associated
with body mass index (BMI), fat mass or waist-to-hip
ratio (WHR) in Danish Caucasians. Furthermore,
Elbein et al 6 did not ®nd linkage between markers
in the 11q13 region and BMI in 42 North European
families with type 2 diabetic siblings. However, in the
Quebec Family study, resting metabolic rate (RMR)
was genetically linked to DNA microsatellite markers
in the vicinity of 11q13.7 Despite the lack of genetic
linkage of the UCP2=UCP3 region in Pima Indians,8
we recently reported an association between poly-
morphisms in UCP2 and UCP3 and sleeping meta-
bolic rate in this population.4 Furthermore, we
recently found that the skeletal muscle expression of
UCP3 mRNA was positively correlated to resting
metabolic rate, in male Pima Indians.9
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To study whether genetic variation in the promoter
region of UCP3 contributes to the variation in
expression of UCP3 and is associated with BMI, we
screened part of the proximal promoter region for
polymorphisms in Pima Indians.
Methods
In the ®rst part of this study, the proximal promoter
region of UCP3 was screened in 24 non-diabetic Pima
Indians (18 males, 6 females), in whom we had
previously measured skeletal muscle UCP3 expres-
sion.9 Subjects had a range in BMI from 18 to
47 kg=m2 (mean s.e.m.: 34 1.4). In the second
part of the study, 67 non-diabetic, full blooded Pima
Indians (32 males, 35 females) were selected from the
extremes in BMI distribution (30 lean, 37 obese). All
subjects were in good health as determined by physi-
cal examination and routine blood and urine tests. All
subjects were clinically euthyroid and serum thyroid
stimulating hormone concentrations were within the
normal range. None took prescribed or over-the-
counter medications. Glucose tolerance was assessed
by an oral glucose tolerance test according to the
WHO criteria,10 and insulin concentrations were also
measured (Concept 4, ICN, Forsham, PA). This study
was approved by the ethics committee of the National
Institute of Diabetes and Digestive and Kidney Dis-
eases and by the Tribal Council of the Gila River
Indian Community, and all subjects gave written
informed consent prior to participation.
Ampli®cation of the UCP3 promoter upstream
( 1 kb) and part of exon 1 was performed by PCR
in a 25ml volume containing 1.5 mmol=l MgCl2, 0.25
units of Amplitaq DNA polymerase (Perkin Elmer,
Foster, CA), and 5 pmol of the oligonucleotide pri-
mers, sense 50-CATGACTTCCCTGAGATTCC and
antisense 50-CTCCCTAGGGCTCCATCC. After 35
cycles, PCR products were puri®ed by the PCR
puri®cation kit (Qiagen, Valencia, CA). Product con-
centration was estimated on a 1% agarose gel.
 200 ng DNA template was used for cycle sequen-
cing following the instruction (Applied Biosystems,
Foster City, CA) with the sense primer 50-
CCTATCGTGGGAGGCCTTG, the above mentioned
antisense primer and dichlororhodamine dye mix.
After removal of excess dye terminators with the
Microspin G-50 column (Pharmacia Biotech, Piscat-
away, New Jersey), samples were electrophoresed and
analysed on an ABI Prism 377 automated sequencer
(PE Applied Biosystems, Foster, CA). The expression
of UCP3 mRNA was determined as previously
described.9
Results
We identi®ed a previously undescribed C to T sub-
stitution in the UCP3 promoter, 6 bp upstream of the
putative TATA signal, and 55 bp upstream of the
Figure 1 Skeletal muscle UCP3 mRNA expression in different genotypes of a UCP3 promoter variant.
*P<0.05 compared to CC.
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transcription starting site, among the 24 subjects. One
was homozygous for the polymorphism (T=T), 6
heterozygous and 17 homozygous for C=C. Because
there was only one T=T homozygote, we compared
UCP3 mRNA expression between the C=C group and
the C=T & T=T group.
In the 18 male subjects, UCP3 mRNA expression
was signi®cantly higher in the C=T and T=T group
compared to the C=C homozygotes (Figure 1),
1.33 0.21 vs 0.84 0.07, P 0.012). When the six
female subjects were included UCP3 mRNA expres-
sion was still signi®cantly higher in the C=T & T=T
group compared to the C=C homozygotes but the P-
value dropped (Figure 1, 1.17 0.13 vs 0.88 0.07,
P< 0.04), possibly implying a gender effect.
However, the expression of UCP3 mRNA was not
signi®cantly different between males and females and
the small number of female subjects does not allow
conclusions on the effect of the polymorphism on
UCP3 mRNA expression in female subjects.
To establish whether this polymorphism was asso-
ciated with BMI, we typed this polymorphism in 67
Pima Indians (32 males, 35 females) from the upper
(BMI: 48.1 5.3 kg=m2) and lower (BMI:
24.2 1.5 kg=m2) extremes of the BMI distribution.
The polymorphism did not alter any restriction site
and therefore genotyping was performed by direct
sequencing in all subjects. In the lean subjects, the
allele frequency was 88.3% for C and 11.7% for T,
whereas in the obese subjects the allele frequency was
78.4% for C and 21.6% for T (NS). The overall allele
frequency in this population was 83% for C and 17%
for the T allele. Genotype frequencies were 76.7% for
CC, 23.3% for CT and 0% for TT in the lean subjects
and 64.9% for CC, 27.0% for CT and 8.1% for TT in
the obese subjects (Table 1). To investigate whether
the allele frequency of this population was different
from Caucasians, we determined allele frequency of
the promoter polymorphism in 56 CEPH Caucasians.
Allele frequency was 75% for the C allele and 25%
for the T allele (NS).
Discussion
The recent discovery of UCP2 and UCP3 in various
tissues has renewed the interest in human energy
metabolism. Uncoupling proteins uncouple oxygen
consumption from ATP production and therefore
stimulate the dissipation of energy as heat. In the
present study we examined whether genetic variation
in the proximal promoter region of UCP3 contributed
to the variability in the expression of UCP3 in Pima
Indians. Mutation screening revealed one novel poly-
morphism, a C to T conversion, located 6 bp upstream
of the TATA signal, and 55 bp upstream of the
transcription initiation site. Although no known tran-
scription factor binding sites exist in this location, the
location of this polymorphism in the proximal pro-
moter region and its proximity to the putative TATA
signal is interesting and warrants further study.
The main goal of the present study was to examine
whether genetic variation in the UCP3 promoter
region contributed to variation in UCP3 expression.
We therefore screened the promoter region of the
UCP3 gene for this novel polymorphism in 24 non-
diabetic Pima Indians, in whom we had previously
measured UCP3 mRNA expression. On average,
UCP3 mRNA expression was 0.96 0.07 (ratio with
b-actin) with a wide range from 0.31 ± 1.66. The C to
T mutation in the proximal promoter region of UCP3
was signi®cantly associated with UCP3 mRNA
expression, at least in the male subjects. In the male
subjects, those with the T allele had, on average, 58%
higher expression of UCP3 in skeletal muscle com-
pared to those subjects without the T allele. The
number of female subjects was too limited to make
conclusion whether this effect was gender speci®c.
These results, together with the location of the muta-
tion, are promising and suggest a role for this poly-
morphism in the regulation of UCP3 gene expression
in humans.
Recently, we showed that the mRNA expression of
UCP3 was positively correlated with sleeping meta-
bolic rate in Pima Indians,9 suggesting that a low
UCP3 mRNA expression may contribute to a low
sleeping metabolic rate. Since a low relative resting
metabolic rate is a predisposing factor for weight
gain,11 it was expected that individuals with low
UCP3 gene expression would eventually have higher
body weight. Indeed, we also found a negative corre-
lation between BMI and UCP3 gene expression.9 To
further investigate the role of the UCP3 promoter
polymorphism, we selected 67 Pima Indians with
extremes in BMI and examined, by direct sequencing,
whether the allele frequency of the C to T mutation
was different between the lean and obese groups. No
signi®cant differences in allele frequency between the
two groups were found. This might indicate that the
effect of the C to T mutation on UCP3 mRNA
expression is minor and not translated in an effect
on BMI. However, since obesity is a highly hetero-
geneous trait even strong effects of polymorphisms on
UCP3 mRNA expression would not necessarily result
in extreme differences in BMI. The selection of Pima
Indians with extremes in BMI may have resulted in a
selection of subjects where major genes are respon-
Table 1 Geneotype frequency of a UCP3 promoter variant in
obese (BMI: 48.15.3 kg=m2) and lean subjects
(24.2 1.5 kg=m2)
Genotype n Lean Obese
Males CC 18 9 9
CT 12 6 6
TT 2 0 2
Females CC 29 14 15
CT 5 1 4
TT 1 0 1
BMIbody mass index.
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sible for the lean or obese phenotype. Therefore,
further studies are required to test whether this poly-
morphism is associated with BMI in other populations
or with other traits, like sleeping metabolic rate, which
are more likely to be directly in¯uenced by UCP3
mRNA expression. Finally, it should be kept in mind
that future studies are needed to reveal whether
differences in UCP3 mRNA are translated into differ-
ences in UCP3 protein content.
Conclusion
In conclusion, we identi®ed a novel polymorphism in
the proximal promoter region of UCP3, near the putative
TATA signal. The C to T mutation was associated with
increased expression of UCP3 in skeletal muscle of male
non-diabetic Pima Indians. Considering the potential
role of UCP3 in energy metabolism, this polymorphism
might be of physiological importance in the regulation
of energy balance.
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